Ann Hake

  • Associate Professor of Clinical Neurology, Neurology
  • 2328 Citations
  • 21 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ann Hake is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Dementia Medicine & Life Sciences
African Americans Medicine & Life Sciences
Amyloid Medicine & Life Sciences
Cognition Medicine & Life Sciences
solanezumab Medicine & Life Sciences
Cholinesterase Inhibitors Medicine & Life Sciences
Selenium Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1998 2019

  • 2328 Citations
  • 21 h-Index
  • 63 Article
  • 1 Chapter
  • 1 Letter
  • 1 Short survey
1 Citation (Scopus)

A blood-based signature of cerebrospinal fluid Aβ 1–42 status

Alzheimer’s Disease Metabolomics Consortium & Alzheimer’s Disease Neuroimaging Initiative, Dec 1 2019, In : Scientific Reports. 9, 1, 4163.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid
Amyloid
Alzheimer Disease
Positron-Emission Tomography
Area Under Curve

Pharmacokinetics and Pharmacodynamics of LY2599666, a PEG-Linked Antigen Binding Fragment that Targets Soluble Monomer Amyloid-β

Li, L., Zhen, E. Y., Decker, R. L., Willis, B. A., Waters, D., Liu, P., Hake, A., Demattos, R. B. & Ayan-Oshodi, M., Jan 1 2019, In : Journal of Alzheimer's Disease. 68, 1, p. 137-144 8 p.

Research output: Contribution to journalArticle

Amyloid
Pharmacokinetics
Antigens
Blood-Brain Barrier
Serum
2 Citations (Scopus)

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

for Alzheimer’s Disease Neuroimaging Initiative, Dec 1 2019, In : Scientific Reports. 9, 1, 1952.

Research output: Contribution to journalArticle

Open Access
Disease Progression
Alzheimer Disease
Learning
Neuroimaging
Area Under Curve

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

for the Alzheimer’s Disease Neuroimaging Initiative, Dec 1 2019, In : Scientific Reports. 9, 1, 2235.

Research output: Contribution to journalArticle

Open Access
Disease Progression
Alzheimer Disease
Demography
Complement C1
Prodromal Symptoms

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

The Alzheimer’s Disease Neuroimaging Initiative (ADNI), Dec 1 2019, In : Nature communications. 10, 1, 1766.

Research output: Contribution to journalArticle

Open Access
nervous system disorder
cognition
genetic marker
pathology
risk factor